biospecimen_aliquot__bcr_aliquot_barcode	tcga-a2-a0cr-01a-11d-a228-09
biospecimen_aliquot__bcr_aliquot_uuid	f573c3c3-7b61-4955-8772-215b7cb9a763
biospecimen_aliquot__bcr_patient_uuid	4cf0f639-7940-48b6-8ea1-2a3494097cdb
biospecimen_aliquot__bcr_sample_barcode	tcga-a2-a0cr-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0118966535
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.09
biospecimen_aliquot__date_of_shipment	2012-05-30
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	1
biospecimen_aliquot__plate_id	a228
biospecimen_aliquot__plate_row	c
biospecimen_aliquot__quantity	3.60
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-a2-a0cr-01a-11d
biospecimen_analyte__bcr_analyte_uuid	9e105193-d51a-4221-ac68-4a5b9c9fb0b4
biospecimen_analyte__bcr_patient_uuid	4cf0f639-7940-48b6-8ea1-2a3494097cdb
biospecimen_analyte__bcr_sample_barcode	tcga-a2-a0cr-01a
biospecimen_analyte__concentration	0.17
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	picogreen
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-a2-a0cr
biospecimen_diagnostic_slides__bcr_patient_uuid	4cf0f639-7940-48b6-8ea1-2a3494097cdb
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-a2-a0cr-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	f7d36ca5-a4c6-443a-aeed-5b23cd924fa3
biospecimen_normal_control__bcr_patient_barcode	tcga-a2-a0cr
biospecimen_normal_control__bcr_patient_uuid	4cf0f639-7940-48b6-8ea1-2a3494097cdb
biospecimen_normal_control__ncedna_dna_conc	0.363
biospecimen_normal_control__ncedna_dna_qm	spec (nanodrop)
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	55.1
biospecimen_portion__bcr_patient_uuid	4cf0f639-7940-48b6-8ea1-2a3494097cdb
biospecimen_portion__bcr_portion_barcode	tcga-a2-a0cr-01a-11
biospecimen_portion__bcr_portion_uuid	b94fe609-2978-43ae-8bc9-614f36ea4733
biospecimen_portion__bcr_sample_barcode	tcga-a2-a0cr-01a
biospecimen_portion__date_of_creation	2012-03-23
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-a2-a0cr-01a-11d
biospecimen_protocol__bcr_patient_uuid	4cf0f639-7940-48b6-8ea1-2a3494097cdb
biospecimen_protocol__bcr_sample_barcode	tcga-a2-a0cr-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	4cf0f639-7940-48b6-8ea1-2a3494097cdb
biospecimen_sample__bcr_sample_barcode	tcga-a2-a0cr-01a
biospecimen_sample__bcr_sample_uuid	7d3dea42-f18f-4cf6-973d-ea2bae39ba38
biospecimen_sample__days_to_collection	2191
biospecimen_sample__initial_weight	280
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-a2-a0cr.a3167e2d-3588-41d4-99aa-6dcb660d55a4.pdf
biospecimen_sample__pathology_report_uuid	a3167e2d-3588-41d4-99aa-6dcb660d55a4
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	4cf0f639-7940-48b6-8ea1-2a3494097cdb
biospecimen_shipment_portion__bcr_sample_barcode	tcga-a2-a0cr-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	3ed7fa0f-b208-4493-aac0-71cb01860ac9
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a24a
biospecimen_shipment_portion__portion_number	22
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-a2-a0cr-01a-22-a24a-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	14
biospecimen_shipment_portion__shipment_portion_month_of_shipment	11
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2012
biospecimen_slide__bcr_patient_uuid	4cf0f639-7940-48b6-8ea1-2a3494097cdb
biospecimen_slide__bcr_sample_barcode	tcga-a2-a0cr-01a
biospecimen_slide__bcr_slide_barcode	tcga-a2-a0cr-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	192598c2-7093-4171-b779-6ede8ad7998b
biospecimen_slide__image_file_name	tcga-a2-a0cr-01a-01-tsa.192598c2-7093-4171-b779-6ede8ad7998b.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	100
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	3
biospecimen_slide__percent_stromal_cells	57
biospecimen_slide__percent_tumor_cells	40
biospecimen_slide__percent_tumor_nuclei	80
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-a2-a0cr
biospecimen_tumor_sample__bcr_patient_uuid	4cf0f639-7940-48b6-8ea1-2a3494097cdb
clinical_drug__bcr_drug_barcode	tcga-a2-a0cr-d32695
clinical_drug__bcr_drug_uuid	4b109ece-53bb-4544-a269-3dbbeffdf432
clinical_drug__bcr_patient_barcode	tcga-a2-a0cr
clinical_drug__bcr_patient_uuid	4cf0f639-7940-48b6-8ea1-2a3494097cdb
clinical_drug__form_completion_date	2012-6-7
clinical_drug__pharmaceutical_therapy_drug_name	anastrazole
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	315
clinical_drug__tx_on_clinical_trial	no
clinical_follow_up__bcr_followup_barcode	tcga-a2-a0cr-f42400
clinical_follow_up__bcr_followup_uuid	c3d189cf-d8dd-4b02-9dd3-68cca1f0579f
clinical_follow_up__bcr_patient_barcode	tcga-a2-a0cr
clinical_follow_up__bcr_patient_uuid	4cf0f639-7940-48b6-8ea1-2a3494097cdb
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2013-4-18
clinical_follow_up__last_contact_days_to	3283
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	54
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t3
clinical_patient__anatomic_neoplasm_subdivision	left upper inner quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-a2-a0cr
clinical_patient__bcr_patient_uuid	4cf0f639-7940-48b6-8ea1-2a3494097cdb
clinical_patient__birth_days_to	-20075
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_ihc_score	1+
clinical_patient__er_positivity_scale_used	3 point scale
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	60-69%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2012-6-5
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	1.2
clinical_patient__her2_fish_status	negative
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2004
clinical_patient__last_contact_days_to	2955
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	16
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__lymph_nodes_examined_ihc_count	0
clinical_patient__margin_status	close
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a0cr
clinical_patient__pr_positivity_ihc_intensity_score	3+
clinical_patient__pr_positivity_scale_used	3 point scale
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	80-89%
clinical_patient__prospective_collection	no
clinical_patient__race	asian
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	a2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A0CR-01A-11D-A228-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A0CR-01A-11D-A228-09.bed.meta
manually_curated__id	tcga-a2-a0cr-01a-11d-a228-09
manually_curated__md5sum	392506e9f8c440ba93a16f34bcca161b
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	f573c3c3-7b61-4955-8772-215b7cb9a763
manually_curated__tumor_tag	brca
